Hot Pursuit     26-Feb-24
Suven Pharma Hyderabad facilities clear USFDA inspection
The inspection was conducted by the US Food & Drug Administration (USFDA) from 12 February 2024 to 23 February 2024.
Suven Pharmaceuticals announced that its active pharmaceutical ingredients (API) and formulations facilities (Unit-3 and Unit-5) in Pashamylaram, Hyderabad, India, have completed the pre-approval inspections (PAI) and good manufacturing practices (GMP) inspections by the US drug regyulator.

The inspection was conducted from 12 February 2024 to 23 February 2024 and no Form 483 has been issued as a result of the inspection, stated the drug maker.

Suven Pharmaceuticals is in the business of Contract Development & Manufacturing Organisation (CDMO), catering to the needs of global pharma industry.

The pharmaceutical company reported 56.60% decline in consolidated net profit to Rs 46.75 crore on 37.86% fall in revenue from operations to Rs 219.82 crore in Q3 FY24 over Q3 FY23.

The scrip rose 0.85% to currently trade at Rs 669.20 on the BSE.

Previous News
  Suven Pharma says Casper Pharma completes USFDA pre-approval inspection
 ( Hot Pursuit - 30-Jul-22   14:55 )
  Suven Pharmaceuticals consolidated net profit declines 0.86% in the March 2020 quarter
 ( Results - Announcements 18-Jun-20   15:15 )
  Volumes spurt at Avanti Feeds Ltd counter
 ( Hot Pursuit - 14-Sep-23   14:30 )
  Volumes spurt at Torrent Power Ltd counter
 ( Hot Pursuit - 31-Jul-24   11:00 )
  Suven Pharmaceuticals Ltd leads losers in 'B' group
 ( Hot Pursuit - 30-Oct-20   14:45 )
  Board of Suvan Pharmaceuticals recommends special dividend
 ( Corporate News - 09-Feb-22   11:24 )
  Suven Pharmaceuticals to conduct board meeting
 ( Corporate News - 31-Jan-23   13:41 )
  Garware Technical Fibres Ltd leads gainers in 'A' group
 ( Hot Pursuit - 19-Sep-24   12:00 )
  Suven Pharmaceuticals appoints Vivek Sharma as new Executive Chairman
 ( Corporate News - 19-Sep-24   19:41 )
  Suven Pharmaceuticals to convene AGM
 ( Corporate News - 10-May-22   15:08 )
  Suven Pharmaceuticals consolidated net profit rises 10.29% in the March 2022 quarter
 ( Results - Announcements 09-May-22   14:13 )
Other Stories
  Avantel Q2 PAT jumps 42% YoY to Rs 23 cr
  05-Oct-24   17:03
  Equitas SFB total deposits jump 29% YoY in Q2 FY25
  05-Oct-24   16:28
  Ujjivan SFB total deposits rises 17% in Q2 FY25
  05-Oct-24   15:34
  L&T Finance retail disbursements jump 12% YoY in Q2 FY25
  05-Oct-24   14:31
  Bandhan Bank records over 21% YoY jump in loan book during Q2 FY25; deposits at Rs 1.42 lakh crore
  05-Oct-24   13:32
  Lupin's Pune-based biotech facility gets 5 observations from US FDA
  05-Oct-24   13:20
  Macrotech Developers pre-sales jumps 21% YoY in Q2 FY25
  05-Oct-24   09:04
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
Back Top